MagicMed to Be Acquired by Nasdaq-Listed Company Post published:May 24, 2021 Post category:Analysis/News
MagicMed Industries Announces Collaboration with Artificial Intelligence Thought Leaders and the Launch of PsyAI™ Post published:March 4, 2021 Post category:Press Release
MagicMed Industries Announces the Establishment of Psilocybin-Derivatives Portfolio and Launch of Candidate Selection Program Post published:December 22, 2020 Post category:Press Release
MagicMed Industries Announces Closing of Upsized and Oversubscribed $8.1 Million Private Placement of Units Led by Gravitas Securities Due to Significant Investor Demand Post published:December 17, 2020 Post category:Press Release
MagicMed Industries Announces $2.5 Million Unit Offering Led by Gravitas Securities Post published:November 10, 2020 Post category:Press Release
MagicMed Industries Announces Agreements with the University of Calgary to Accelerate Development of the MagicMed Psybrary™ Post published:October 30, 2020 Post category:Press Release
MagicMed Industries Closes Oversubscribed Private Placement for $1,642,880 with Mackie Research Capital Corporation Post published:September 2, 2020 Post category:Press Release
MagicMed Industries Inc. Announces Brokered Private Placement with Mackie Research Capital Corporation Post published:July 20, 2020 Post category:Press Release
MagicMed Industries Files First Psychedelic Derivative Patent Post published:July 9, 2020 Post category:Press Release